Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

Nav

General Info

Geography

Italy (ITA)

Time period covered

01/2000 - 12/2007

Data type

Scientific literature

Keywords

Blood disorders, Drug resistance, E. coli, Mortality

Citation

Authors

Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, Fadda G, Leone G, Cauda R, Pagano L

Journal

J Infect

Volume

Issue

Pages

299-307

Publication year

2009

Suggested citation

Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, Fadda G, Leone G, Cauda R, Pagano L. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect. 2009; 58(4): 299-307.

DOI

10.1016/j.jinf.2009.02.002

PMID

19272650

GHDx Entry last modified on: Sep 17, 2024

Header sites

Search form

Main menu

Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

Nav